Vault-13

GENERAL ATLANTIC, L.P.

New York, NY · CIK 1017645 · 13F filing filed 2023-08-11

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$6.3bn reported value -26.3% vs Q1 2023
30positions
86.8%in top 10
4 new 4 added 1 reduced 5 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ENGAGESMART INC COMMON STOCK ESMT ESMT 90,271,540 $1.7bn27.16% 27.16% UnchangedShares held: Q3 2022 97.2m, Q4 2022 97.2m, Q1 2023 90.3m, Q2 2023 90.3m
2 DLOCAL LTD CLASS A COM DLO DLO 63,906,695 $780.0m12.29% 12.29% AddedShares held: Q3 2022 57.3m, Q4 2022 57.7m, Q1 2023 61.7m, Q2 2023 63.9m +2.2m +2,160,680 3.5%
3 SQUARESPACE INC CLASS A SQSP SQSP 22,361,073 $705.3m11.12% 11.12% UnchangedShares held: Q3 2022 22.4m, Q4 2022 22.4m, Q1 2023 22.4m, Q2 2023 22.4m
4 XP INC CL A XP XP 29,617,733 $694.8m10.95% 10.95% AddedShares held: Q3 2022 25.3m, Q4 2022 25.3m, Q1 2023 25.3m, Q2 2023 29.6m +4.3m +4,300,000 17.0%
5 HIRERIGHT HOLDINGS CORPORATI COM COM 32,109,898 $363.2m5.72% 5.72% UnchangedShares held: Q3 2022 29.7m, Q4 2022 32.1m, Q1 2023 32.1m, Q2 2023 32.1m
6 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 60,993,323 $350.7m5.53% 5.53% UnchangedShares held: Q3 2022 61.0m, Q4 2022 61.0m, Q1 2023 61.0m, Q2 2023 61.0m
7 ALKAMI TECHNOLOGY INC COM ALKT ALKT 18,729,806 $307.0m4.84% 4.84% UnchangedShares held: Q3 2022 18.7m, Q4 2022 18.7m, Q1 2023 18.7m, Q2 2023 18.7m
8 EUROPEAN WAX CTR INC CLASS A COM EWCZ EWCZ 13,110,492 $244.2m3.85% 3.85% UnchangedShares held: Q3 2022 13.1m, Q4 2022 13.1m, Q1 2023 13.1m, Q2 2023 13.1m
9 MOBILEYE GLOBAL INC COMMON CLASS A MBLY MBLY 4,761,905 $183.0m2.88% 2.88% UnchangedShares held: Q3 2022 0, Q4 2022 4.8m, Q1 2023 4.8m, Q2 2023 4.8m
10 KARUNA THERAPEUTICS INC COM COM 726,958 $157.6m2.48% 2.48% AddedShares held: Q3 2022 415.0k, Q4 2022 716.2k, Q1 2023 716.2k, Q2 2023 727.0k +10.8k +10,800 1.5%
11 CLEAR SECURE INC COM CL A YOU YOU 4,861,120 $112.6m1.78% 1.78% UnchangedShares held: Q3 2022 7.0m, Q4 2022 7.0m, Q1 2023 4.9m, Q2 2023 4.9m
12 AKERO THERAPEUTICS INC COM AKRO AKRO 1,785,714 $83.4m1.31% 1.31% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.8m
13 DUOLINGO INC CL A COM DUOL DUOL 580,642 $83.0m1.31% 1.31% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.2m, Q2 2023 580.6k -583.7k -583,652 -50.1%
14 PHARVARIS N V COM PHVS PHVS 4,406,252 $66.7m1.05% 1.05% AddedShares held: Q3 2022 2.4m, Q4 2022 2.4m, Q1 2023 2.4m, Q2 2023 4.4m +2.0m +1,986,097 82.1%
15 GINKGO BIOWORKS HOLDINGS INC CL A SHS CL A SHS 32,319,896 $60.1m0.95% 0.95% UnchangedShares held: Q3 2022 32.3m, Q4 2022 32.3m, Q1 2023 32.3m, Q2 2023 32.3m
16 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 9,681,818 $59.9m0.94% 0.94% UnchangedShares held: Q3 2022 9.7m, Q4 2022 9.7m, Q1 2023 9.7m, Q2 2023 9.7m
17 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 950,000 $57.0m0.90% 0.90% UnchangedShares held: Q3 2022 950.0k, Q4 2022 950.0k, Q1 2023 950.0k, Q2 2023 950.0k
18 ARCO PLATFORM LTD COM CL A COM CL A 4,103,366 $49.8m0.79% 0.79% UnchangedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 4.1m, Q2 2023 4.1m
19 HUTCHMED CHINA LTD SPONSORED ADS HCM HCM 4,000,000 $48.0m0.76% 0.76% UnchangedShares held: Q3 2022 4.0m, Q4 2022 4.0m, Q1 2023 4.0m, Q2 2023 4.0m
20 ROYALTY PHARMA PLC SHS CLASS A RPRX RPRX 1,500,000 $46.1m0.73% 0.73% UnchangedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m
21 FUTU HLDGS LTD SPON ADS CL A FUTU FUTU 1,111,544 $44.2m0.70% 0.70% UnchangedShares held: Q3 2022 0, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m
22 ACELYRIN INC COM COM 1,500,000 $31.4m0.49% 0.49% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.5m
23 RISKIFIED LTD SHS CL A RSKD RSKD 5,324,998 $25.9m0.41% 0.41% UnchangedShares held: Q3 2022 5.3m, Q4 2022 5.3m, Q1 2023 5.3m, Q2 2023 5.3m
24 OPENDOOR TECHNOLOGIES INC COM OPEN OPEN 6,321,519 $25.4m0.40% 0.40% UnchangedShares held: Q3 2022 6.3m, Q4 2022 6.3m, Q1 2023 6.3m, Q2 2023 6.3m
25 BLEND LABS INC CL A BLND BLND 19,132,440 $18.1m0.29% 0.29% UnchangedShares held: Q3 2022 11.4m, Q4 2022 11.4m, Q1 2023 19.1m, Q2 2023 19.1m
26 THIRD HARMONIC BIO INC COM COM 2,958,762 $14.2m0.22% 0.22% UnchangedShares held: Q3 2022 3.0m, Q4 2022 3.0m, Q1 2023 3.0m, Q2 2023 3.0m
27 CONTEXTLOGIC INC CL A NEW LOGC LOGC 609,615 $4.0m0.06% 0.06% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 609.6k
28 BUZZFEED INC CLASS A COM CLASS A COM 7,862,502 $4.0m0.06% 0.06% UnchangedShares held: Q3 2022 7.9m, Q4 2022 7.9m, Q1 2023 7.9m, Q2 2023 7.9m
29 GROVE COLLABORATIVE HOLD INC COM CL A GROV GROV 936,020 $1.7m0.03% 0.03% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 936.0k
30 ADAGENE INC ADS ADAG ADAG 264,000 $390.7k0.01% 0.01% UnchangedShares held: Q3 2022 264.0k, Q4 2022 264.0k, Q1 2023 264.0k, Q2 2023 264.0k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
OAK STR HEALTH INC 61,384,475 $2.4bn61.4m shares
SAMSARA INC IOT IOT 9,227,020 $182.0m9.2m shares
CHINA INDEX HLDGS LTD 10,122,769 $9.5m10.1m shares
CONTEXTLOGIC INC 18,288,478 $8.2m18.3m shares
GROVE COLLABORATIVE HOLD INC 936,020 $2.0m936.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
DLOCAL LTD DLO · 13D · filed 2026-08-19 DLO 21.4%≈ $478.4m -6.9 pts 13D 2026-08-19
ALKAMI TECHNOLOGY INC ALKT · 13D · filed 2026-05-15 ALKT 18.1%≈ $351.9m +1.8 pts 13D 2026-05-15
LIFTOFF MOBILE INC LFTO · 13D · filed 2026-06-12 LFTO 15.0%≈ $608.1m new 13D 2026-06-12
SEAPORT THERAPEUTICS INC SPTX · 13D · filed 2026-05-11 SPTX 11.5%≈ $132.5m new 13D 2026-05-11
AKERO THERAPEUTICS INC AKRO · 13G · filed 2025-05-15 AKRO 8.4% 13G 2025-05-15
PHARVARIS N V PHVS · 13G · filed 2026-08-14 PHVS 7.6%≈ $185.3m 13G 2026-08-14
CHIME FINL INC CHYM · 13G · filed 2025-11-10 CHYM 5.6%≈ $393.4m new 13G 2025-11-10
XP INC XP · 13D · filed 2025-12-04 XP 5.4%≈ $370.1m 13D 2025-12-04